News
PRGO
31.94
-0.62%
-0.20
Enfamil Manufacturer Reckitt Sees Infant Formula Shortage Continuing Until Spring
Benzinga · 3d ago
‘Long-term investors should turn back toward stocks’: J.P. Morgan says inflation has peaked and suggests 2 stocks to buy
For well over a year now, we’ve been seeing headlines about inflation. The rate of price increases is running at its highest level since the early 1980s, although the October numbers, just released, showed it cooling off to 7.7% over the past 12 months. Co...
TipRanks · 11/10 15:12
Raymond James Maintains Outperform on Perrigo, Lowers Price Target to $42
Benzinga · 11/09 12:36
--Raymond James Adjusts Price Target on Perrigo Company to $42 From $48, Maintains Outperform Rating
--Raymond James Adjusts Price Target on Perrigo Company to $42 From $48, Maintains Outperform Rating
MT Newswires · 11/09 10:43
Why Party City Holdco Shares Tumbled Over 40%; Here Are 98 Biggest Movers From Yesterday
Benzinga · 11/09 10:08
Why TaskUs Shares Are Trading Higher By 37%? Here Are 77 Stocks Moving In Tuesday's Mid-Day Session
Benzinga · 11/08 17:51
Perrigo, Tripadvisor, Lyft, And Some Other Big Stocks Moving Lower On Tuesday
Benzinga · 11/08 16:30
Perrigo Shares Fall As Investors React To Lowered FY22 Profit Guidance
Benzinga · 11/08 14:52
Perrigo falls 10% as forex headwinds lead to Q3 miss and guidance cut
Seekingalpha · 11/08 13:16
BRIEF-Perrigo Reports Q3 Loss Of $0.39 Per Share
Reuters · 11/08 11:38
Perrigo Non-GAAP EPS of $0.56 misses by $0.11, revenue of $1.1B misses by $40M, lowers FY adj. EPS guidance
Seekingalpha · 11/08 11:36
Perrigo Co Adj Q3 EPS $0.56 Up From $0.45 YoY, Sales $1.10B Beat $1.10B Estimate
Benzinga · 11/08 11:33
Perrigo Reports Third Quarter Fiscal Year 2022 Financial Results From Continuing Operations
Perrigo Reports Third Quarter Fiscal Year 2022 Financial Results From Continuing Operations
PR Newswire · 11/08 11:30
Perrigo Reports Higher Fiscal Q3 Adjusted Profit, Net Sales; Cuts Fiscal 2022 Adjusted EPS Outlook
Perrigo Reports Higher Fiscal Q3 Adjusted Profit, Net Sales; Cuts Fiscal 2022 Adjusted EPS Outlook
MT Newswires · 11/08 07:05
-- Earnings Flash (PRGO) PERRIGO COMPANY Reports Q3 Revenue $1.10B, vs. Street Est of $1.14B
-- Earnings Flash (PRGO) PERRIGO COMPANY Reports Q3 Revenue $1.10B, vs. Street Est of $1.14B
MT Newswires · 11/08 06:48
-- Earnings Flash (PRGO) PERRIGO COMPANY Reports Q3 EPS $0.56, vs. Street Est of $0.67
-- Earnings Flash (PRGO) PERRIGO COMPANY Reports Q3 EPS $0.56, vs. Street Est of $0.67
MT Newswires · 11/08 06:40
Notable earnings before Tuesday's open
Seekingalpha · 11/07 16:03
Perrigo declares $0.26 dividend
Seekingalpha · 11/03 16:05
Perrigo Announces Quarterly Dividend
Perrigo Company plc (NYSE: PRGO), a leading global provider of Consumer Self-Care Products, today announced that its Board of Directors declared a quarterly dividend of $0.26 per share, payable on December 20, 2022, to shareholders of record on December 2,...
PR Newswire · 11/03 16:00
Swiss stocks - Factors to watch on November 2
Reuters · 11/02 05:37
More
Webull provides a variety of real-time PRGO stock news. You can receive the latest news about Perrigo Co Plc through multiple platforms. This information may help you make smarter investment decisions.
About PRGO
Perrigo Company plc is a provider of over the counter (OTC) health and wellness solutions that enables consumers to prevent or treat conditions that can be self-managed. The Company operates through two segments: Consumer Self-Care Americas (CSCA) and Consumer Self-Care International (CSCI). The CSCA segment comprises consumer self-care business (OTC, infant formula, and oral self-care categories, and contract manufacturing) in the United States (U.S) and Canada. CSCA segment products sold under brands, such as Prevacid 24HR, Good Sense, Zephrex D, ScarAway, Plackers, Rembrandt, Steripod, Firefly, REACH, Dr. Fresh, and Burt's Bees. The CSCI segment comprises consumer self-care business primarily branded in Europe and Australia, store brand business in the United Kingdom and parts of Europe and Asia. The CSCI segment primarily focuses on building local and regional brands sold through merchandisers, drug stores, pharmacies, and e-commerce channels.